logo

Amgen Inc. (AMGN)



Trade AMGN now with
  Date
  Headline
1/29/2019 4:02:02 PM Amgen Q4 GAAP EPS Increase To $3.01
1/24/2019 4:01:25 PM Amgen Secures NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events
1/24/2019 9:03:26 AM Amgen And Allergan Announce Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab
1/22/2019 9:04:13 AM Amgen Says EC Approved An Expanded Indication For BLINCYTO (blinatumomab) Monotherapy
1/16/2019 5:42:50 PM Amgen, UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For EVENITY
1/2/2019 8:29:33 PM Teva And Amgen Resolve Dispute Over Teva’s Generic Cinacalet HCl Product
12/18/2018 11:01:52 PM Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
12/17/2018 9:03:00 AM Amgen Submits BLA To FDA For ABP 710, A Biosimilar Candidate To REMICADE
12/7/2018 4:21:12 PM Amgen Inc. (AMGN) Declares Quarterly Dividend of $ 1.45, Record Date 2/15/2019
12/7/2018 4:03:40 PM Amgen Declares Q1 Dividend Of $1.45, Payable March 8/ Record Feb. 15
12/3/2018 9:30:46 PM Amgen Announces First-In-Human Data Evaluating Investigational Novel BiTE Immunotherapies AMG 420 And AMG 330